Status:
COMPLETED
Well-being in IBS: Strengths and Happiness (WISH)
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Harvard Medical School (HMS and HSDM)
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this pilot study is to examine the feasibility, acceptability, and preliminary efficacy of a customized positive psychology (PP) intervention for patients with irritable bowel syndrome ...
Detailed Description
Irritable bowel syndrome (IBS), a disorder of gut-brain interaction (DGBI; formerly known as functional gastrointestinal disorder) is characterized by abdominal pain and altered bowel habits, and conc...
Eligibility Criteria
Inclusion
- IBS Diagnosis: Adult patients with an IBS diagnosis documented by the patient's primary care or GI clinician and meeting standardized ROME IV diagnostic criteria.
- Language and communication: English fluency and access to a telephone.
Exclusion
- Severe psychiatric illness: Current manic episode, psychosis, or active substance use disorder diagnosed via the Mini International Neuropsychiatric Interview (MINI).
- Cognitive impairment: Assessed using a six-item cognitive screen developed for research.
Key Trial Info
Start Date :
March 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 11 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05289089
Start Date
March 25 2022
End Date
April 11 2023
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114